We're pleased to welcome Elaine Hoffman, PhD to RTI-HS as Director, Data Analytics and Design Strategy. We sat down with Elaine to learn more about her background and what she brings to our team. Here are her responses.
RTI-HS researcher James Kaye, MD, DrPH, Senior Director, Epidemiology presented a real-world example of the effect of bias in epidemiological studies during a recent presentation to students and faculty at the University of North Carolina Gillings School of Global Public Health.
During American Heart Month, RTI-HS is joining with patient advocacy groups and the medical, research, and pharmaceutical industries in raising awareness for the continued need for research to support people affected by cardiovascular disease.
RTI-HS Vice President of Health Economics, Josephine Mauskopf, PhD, was named co-chair of the recently-approved International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Economic Evaluation of Vaccines Designed to Prevent Infectious Disease: Good Practices Task Force.
RESEARCH TRIANGLE PARK, NC— Without increasing community-based psychiatric services, a large number of additional state psychiatric hospital beds would be needed to make a substantial impact on the average wait time to admission for people in crisis in North Carolina, according to a study co-...
RESEARCH TRIANGLE PARK, NC— Approximately 34 percent of children in the United States do not receive all doses of vaccines recommended by the Advisory Committee on Immunization Practices (ACIP) by age 2, according to a...
During American Diabetes Month, RTI-HS is joining with patient advocacy groups and the medical, research, and pharmaceutical industries in raising awareness for the nearly 30 million children and adults in the United States managing the disease.
RTI-HS’s expertise in research that measures how patients feel or function has been tapped for the November Special Section on Clinical Outcome Assessments in Therapeutic Innovation & Regulatory Science, the official journal of DIA.
RESEARCH TRIANGLE PARK, NC – Pharmaceutical research experts from RTI Health Solutions, a business unit of RTI International, will share their recent research at the International Society for Pharmacoeconomics and Outcomes Research 18th Annual European Congress Nov. 8-11 in Milan, Italy.
A study co-authored by RTI-HS outcomes researcher, Ravi Goyal, demonstrates that not all breast cancer survivors follow through with prescribed therapy to reduce their risk of recurrence.
September is National Pain Awareness Month, and RTI-HS joins patient advocacy groups and the medical, research, and pharmaceutical industries in raising awareness and promoting research to better understand and develop treatments for chronic pain sufferers.
RESEARCH TRIANGLE PARK, NC – Reducing the number of preventable hospitalizations and emergency room visits from accidental over-the-counter acetaminophen overdose may require special efforts for regular acetaminophen users, heavy alcohol consumers and healthcare professionals.
It is estimated that 47.5 million people worldwide are living with dementia, caused by a variety of brain illnesses including Alzheimer’s.
During World Alzheimer’s Awareness Month in September, we’re highlighting some of our research to bring attention to the disease and its impact on...
We had over 25 researchers attending and moderating sessions, conducting short courses, and presenting their research this year at the International Conference on Pharmacoepidemiology & Therapeutic Risk Management (ICPE) in Boston. Here are some of their takeaways.
Of the 7.5 million people living with psoriasis or psoriatic arthritis, over half say it is a problem in their day-to-day lives.
We have published 80 posters/articles with research findings on the disease and its impact. We’re highlighting some of this research to bring attention to...
August is National Immunization Awareness Month, and RTI-HS joins the CDC and the medical, research, and pharmaceutical industries in raising awareness for the importance of protecting your health by getting vaccinated throughout your lifespan.
Treena Jackson, MS, Quality Assurance Supervisor at RTI-HS, authored the chapter on Pharmacovigilance and Risk Management for Fundamentals of US Regulatory Affairs, Ninth Edition, published on July 31.
RESEARCH TRIANGLE PARK, NC — Christopher Knight has returned as a Senior Director of Health Economics to RTI Health Solutions, a business unit of RTI International.
Join us in welcoming the return of Chris Knight to RTI-HS as Senior Director of Health Economics. Chris manages projects using health economics, Markov modeling, simulation modeling, and statistical modeling techniques to explore disease progression and the impact of treatment. We recently sat...
Allen Mangel, MD, PhD, and Executive Vice President of RTI-HS is co-author on a new study that provides additional support for the idea that the aorta takes an active role in the cardiac cycle.
MANCHESTER, UK—Sorrel Wolowacz, Ph.D., Head of European Health Economics at RTI Health Solutions (RTI-HS), a business unit of RTI International, has joined the editorial board of the Journal of Comparative Effectiveness Research.
Mark Morrison, Director of Business Development, and I attended the American Diabetes Association 2015 Scientific Sessions, which were held in Boston June 5-9. This is the most important meeting of the year specifically devoted to diabetes, and it attracted approximately 18,000 attendees. ...
Dr. Brett Hauber, Senior Economist and VP, Health Preference Assessment, led the effort to create the first catalog that details the range of research methods available to collect and analyze patient preference information.
37 RTI-HS researchers were recognized at the annual RTI International (parent company to RTI-HS) Authors' Awards Dinner for excellence in publishing their research in peer-reviewed journals, books and other highly visible media.
With patients taking more of an active role in their healthcare choices, cost pressures from payers, and the FDA mandate to consider the perspectives of patients during regulatory discussions, it's more important than ever for drug companies to know more than if a medication is safe and...